ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys Back 400,000 Shares

LONDON--GlaxoSmithKline PLC (GSK.LN) Monday announced it purchased 400,000 ordinary shares, to hold in treasury, on Aug. 6. MAIN FACTS: -Highest price paid per share was 1509.5 pence per share. -Lowest price paid per share was 1487 pence per share. -Shares on Monday closed at 1505 pence. -Write to Tapan Panchal at tapan.panchal@dowjones.com Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Glaxosmithkline (GSK)
DateTimeHeadline
12/05/201607:30:00Adaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma...
12/02/201613:20:43Report of Foreign Issuer (6-k)
12/02/201611:07:11Report of Foreign Issuer (6-k)
12/02/201609:56:00GlaxoSmithKline Files for Approval of Three Drugs
12/02/201609:15:00GSK Files Regulatory Submission in European Union for Once-Daily...
12/02/201607:11:09Report of Foreign Issuer (6-k)
12/02/201602:00:00Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use i...
12/01/201609:48:40Report of Foreign Issuer (6-k)
11/30/201613:37:12Report of Foreign Issuer (6-k)
11/25/201610:29:04Report of Foreign Issuer (6-k)
11/25/201609:10:00GlaxoSmithKline Sumbits Application For Shingles Treatment Shingrix
11/25/201608:00:26Report of Foreign Issuer (6-k)
11/24/201606:46:00GlaxoSmithKline Starts Phase III Studies with Daprodustat
11/23/201608:08:14Report of Foreign Issuer (6-k)
11/23/201602:56:00GlaxoSmithKline: Mepolizumab Meets Major Targets in Phase III...
11/21/201608:28:00GSK receives FDA approval for expanded indication for FluLaval®...
11/21/201607:00:00GSK files regulatory submission in US for once-daily closed triple...
11/21/201606:19:12Report of Foreign Issuer (6-k)
11/21/201602:00:00GSK Files Regulatory Submission in US for Once-Daily Closed Triple...
11/18/201612:16:43Report of Foreign Issuer (6-k)

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US